Literature DB >> 9514882

A role for protein kinase C alpha in stimulation of prostaglandin G/H synthase-2 transcription by 14,15-epoxyeicosatrienoic acid.

K G Peri1, G Almazan, D R Varma, S Chemtob.   

Abstract

Arachidonic acid, but not eicosapentaenoic acid, increased prostaglandin G/H endoperoxide synthase-2 transcription in cultured intestinal epithelial cells. This stimulatory effect on PGHS-2 synthesis was prevented by an AA utilization inhibitor, eicosatetraynoic acid. Specific inhibitors of the cyclooxygenase or the lipoxygenase pathways of AA metabolism did not prevent AA-mediated induction of PGHS-2 synthesis; however, the involvement of cytochrome P450 monoxygenases (CYP450) was indicated as several CYP450 blockers, ketoconazole, miconazole, and metyrapone, inhibited the induction of PGHS-2 mRNA synthesis by AA. This blockade by CYP450 inhibitors could be overcome by the addition of the AA epoxygenase metabolite 14,15-epoxyeicosatrienoic acid (14,15-EET); other EET regio-isomers were unable to elevate PGHS-2 mRNA level. Blockade of protein kinase C with a specific inhibitor, bisindolyl maleimide-1, or translational inhibition of protein kinase C alpha by antisense oligonucleotides reduced PGHS-2 transcription, suggesting the involvement of protein kinase C alpha in the signal transduction pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9514882     DOI: 10.1006/bbrc.1998.8215

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

Review 1.  Epoxygenase metabolites. Epithelial and vascular actions.

Authors:  J D Imig
Journal:  Mol Biotechnol       Date:  2000-11       Impact factor: 2.695

2.  Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors.

Authors:  David J Granville; Babak Tashakkor; Cindy Takeuchi; Asa B Gustafsson; Chengqun Huang; M Richard Sayen; Paul Wentworth; Mark Yeager; Roberta A Gottlieb
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-20       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.